Xenetic Biosciences annual net profit margin
2012
2012
2013
2013
2016
2017
2019
2020
2021
2022
2023
2024
2025
Xenetic Biosciences Net Profit Margin Growth & History (XBIO)
Xenetic Biosciences's net profit margin was −90.07% for fiscal 2025.
View full Xenetic Biosciences company overviewXenetic Biosciences annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −90.07% | +68.32 pp |
| 2024 | 2024-12-31 | −158.39% | +4.39 pp |
| 2023 | 2023-12-31 | −162.78% | +221.09 pp |
| 2022 | 2022-12-31 | −383.87% | +102.49 pp |
| 2021 | 2021-12-31 | −486.36% | +2006.75 pp |
| 2020 | 2020-12-31 | −2,493.11% | +72363.47 pp |
| 2019 | 2019-12-31 | −74,856.59% | — |
| 2017 | 2017-12-31 | −47.40% | +1759.47 pp |
| 2016 | 2016-12-31 | −1,806.87% | — |
| 2013 · Dec 31 | 2013-12-31 | −857.92% | +1297.48 pp |
| 2013 · Aug 31 | 2013-08-31 | −92.02% | −12.96 pp |
| 2012 · Dec 31 | 2012-12-31 | −2,155.41% | — |
| 2012 · Aug 31 | 2012-08-31 | −79.06% | — |
Xenetic Biosciences quarterly net profit margin
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.13
Q2.13
Q2.13
Q1.14
Q3.17
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −140.73% | −23.99 pp |
| Q1 2026 | 2026-03-31 | −56.56% | +95.68 pp |
| Q4 2025 | 2025-12-31 | −75.57% | +86.96 pp |
| Q3 2025 | 2025-09-30 | −49.66% | +21.44 pp |
| Q2 2025 | 2025-06-30 | −116.75% | +58.63 pp |
| Q1 2025 | 2025-03-31 | −152.23% | +81.73 pp |
| Q4 2024 | 2024-12-31 | −162.53% | +11.81 pp |
| Q3 2024 | 2024-09-30 | −71.09% | +101.62 pp |
| Q2 2024 | 2024-06-30 | −175.38% | −13.94 pp |
| Q1 2024 | 2024-03-31 | −233.96% | −92.58 pp |
| Q4 2023 | 2023-12-31 | −174.34% | +130.10 pp |
| Q3 2023 | 2023-09-30 | −172.71% | +21.38 pp |
| Q2 2023 | 2023-06-30 | −161.44% | +479.82 pp |
| Q1 2023 | 2023-03-31 | −141.38% | +268.29 pp |
| Q4 2022 | 2022-12-31 | −304.44% | +249.28 pp |
| Q3 2022 | 2022-09-30 | −194.09% | +192.68 pp |
| Q2 2022 | 2022-06-30 | −641.26% | −256.47 pp |
| Q1 2022 | 2022-03-31 | −409.68% | +294.21 pp |
| Q4 2021 | 2021-12-31 | −553.72% | +239.26 pp |
| Q3 2021 | 2021-09-30 | −386.77% | +6134.50 pp |
| Q2 2021 | 2021-06-30 | −384.79% | +459.68 pp |
| Q1 2021 | 2021-03-31 | −703.89% | +1374.44 pp |
| Q4 2020 | 2020-12-31 | −792.98% | +6064.21 pp |
| Q3 2020 | 2020-09-30 | −6,521.27% | — |
| Q2 2020 | 2020-06-30 | −844.48% | — |
| Q1 2020 | 2020-03-31 | −2,078.33% | — |
| Q4 2019 | 2019-12-31 | −6,857.18% | — |
| Q3 2017 | 2017-09-30 | −2,654.00% | — |
| Q1 2014 · Nov 30 | 2013-11-30 | −3,801.84% | −3757.92 pp |
| Q2 2013 · Jun 30 | 2013-06-30 | −93.83% | — |
| Q2 2013 · May 31 | 2013-05-31 | −34.72% | +71.94 pp |
| Q1 2013 · Feb 28 | 2013-02-28 | 46.32% | +127.68 pp |
| Q1 2013 · Nov 30 | 2012-11-30 | −43.92% | +88.22 pp |
| Q4 2012 | 2012-08-31 | −10.81% | — |
| Q3 2012 | 2012-05-31 | −106.66% | — |
| Q2 2012 | 2012-02-29 | −81.36% | — |
| Q1 2012 | 2011-11-30 | −132.15% | — |
Xenetic Biosciences net profit margin trends
Over the last five fiscal years, Xenetic Biosciences's net profit margin increased from −2,493.11% to −90.07%, a change of +2403.04 percentage points. The latest reported quarter, Q2 2026, shows −140.73%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xenetic Biosciences source filings ↗